Found 336 matching trials
Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation PHASE1 RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Show More Location
Mayo Clinic Scottsdale
Learn More & Join Trial
Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients PHASE3 The purpose of this study is to compare a standard chemotherapy regimen of ...
Show More Location
112 sites UK wide
Treatments Being Tested
Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimen Induction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimen Induction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimen Induction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimen Induction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimen Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen Maintenance (intensive & non-intensive pathways) - lenalidomide maintenance Maintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenance High dose melphalan therapy and autologous stem cell transplant (intensive pathway only) Learn More & Join Trial
A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas PHASE1 This is a pilot clinical trial investigating the addition of haploidentical...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma PHASE3 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Fred Hutchinson Cancer Research Center
Learn More & Join Trial
Efficacy of Bortezomib Consolidation After High-dose Melphalan With Stem Cell Support in Myeloma Patients PHASE3 Multiple myeloma is a malignant incurable hematological disease where survi...
Show More Location
Hæmatologisk afdeling B, Aalborg Sygehus Syd
Learn More & Join Trial
Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma PHASE2 Patients included in the study will receive induction treatment during 6 mo...
Show More Status
Active Not Recruiting
Location
Hospital Clínic de Barcelona
Learn More & Join Trial
Combination High Dose Melphalan and Autologous Peripheral Blood Stem Cell (PBSC) Transplant With Bortezomib for Multiple Myeloma: A Dose and Schedule Finding Study PHASE1 The goal of this study is to evaluate the safety of melphalan and autologou...
Show More Location
Emory University Winship Cancer Institute
Learn More & Join Trial
Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance Therapy PHASE2 The purpose of this study is to evaluate the effectiveness of induction the...
Show More Location
Duke University Medical Center
Learn More & Join Trial
Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma PHASE2 RATIONALE: Bortezomib and thalidomide may stop the growth of multiple myelo...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled Trial PHASE2 Oral and intestinal mucositis are major risk factors for the occurrence of ...
Show More Location
Amsterdam UMC, location AMC
Learn More & Join Trial